Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical pimecrolimus for early-stage mycosis fungoides
2014-001377-14Phase 2Active
- Sponsor
- Fundación para la Investigación Biomédica del Hospital 12 de Octubre
- Start
- May 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pimecrolimus in mycosis fungoides (MF), sponsored by Fundación para la Investigación Biomédica del Hospital 12 de Octubre. Primary endpoint: Objective response rate. Started May 2014; status: active.
02
Drugs
pimecrolimus
03
Conditions
mycosis fungoides (MF)
Beyond the preview
Go deeper on 2014-001377-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001377-14.